Bellissa Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Kolkata, West Bengal, India, established in 2014.
2014 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Bellissa Pharmaceuticals Private Limited

Bellissa Pharmaceuticals Private Limited, a active private limited company, was established on 27 November 2014 in Kolkata, West Bengal, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U33111WB2014PTC204431. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.75 M.

It upholds a compliant status. Employing 70 professional, Its leadership includes Magna Chacko (Director), Chacko Puthumana Mathai (Managing Director). Past directors included Anjan Kumar Karak, Pulak Midya, Chacko Puthumana Mathai. It holds ₹8.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 17/43, N.S.C Bose Road 2/30, Ashoke Nagar, Kolkata, West Bengal, 700040.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33111WB2014PTC204431

  • Registration Number

    204431

  • Incorporation Date

    27 November 2014

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹0.75 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 0.75 M
  • Company Age 11 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.00 M
  • Revenue Growth **** 27.75%
  • Profit Growth **** 31.09%
  • Ebitda **** 70.24%
  • Net Worth 27.25%
  • Total Assets **** 56.59%
Company report

Bellissa Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bellissa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bellissa Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Magna Chacko Director 27 Nov 2014 Current
Chacko Puthumana Mathai Managing Director 27 Nov 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Feb 2015 Past
Pramod Abcsdd Director 24 Feb 2015 Past
Pramod Abcsdd Director 02 Dec 2014 Past
Pramod Abcsdd Director 24 Feb 2015 Past
Pramod Abcsdd Director 23 Feb 2015 Past
Pramod Abcsdd Director 24 Feb 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bellissa Pharmaceuticals.

Bellissa Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.75% increase. The company also saw a substantial improvement in profitability, with a 31.09% increase in profit. The company's net worth Soared by an impressive increase of 27.25%.

Bellissa Pharmaceuticals revenue growth over time
Bellissa Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 27.75%
*******
*******
*******
*******
Revenue from Operations
*******
 27.23%
*******
*******
*******
*******
Total Assets
*******
 56.59%
*******
*******
*******
*******
Profit or Loss
*******
 31.09%
*******
*******
*******
*******
Net Worth
*******
 27.25%
*******
*******
*******
*******
EBITDA
*******
 70.24%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bellissa Pharmaceuticals?

Unlock access to Bellissa Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.80 Cr
Latest Charge Details
Date Lender Amount Status
15 Feb 2023 Others ₹8.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Bellissa Pharmaceuticals?

Bellissa Pharmaceuticals has a workforce of 70 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bellissa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bellissa Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bellissa Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Bellissa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Bellissa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 8.00 M with Charge ID 100697925 was registered on 15 Feb 2023. was documented.

  • Director Appointment

    Magna Chacko was appointed as a Director was appointed as a Director on 27 Nov 2014 & has been associated with this company since 11 years 4 months . was recorded as a recent event.

  • Director Appointment

    Chacko Puthumana Mathai was appointed as a Managing Director was appointed as a Managing Director on 27 Nov 2014 & has been associated with this company since 11 years 4 months . was recorded as a recent event.

  • Company Incorporation

    The activity Bellissa Pharmaceuticals Private Limited was registered on 27 Nov 2014 with Roc Kolkata & aged 11 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bellissa Pharmaceuticals Private Limited?

The CIN of Bellissa Pharmaceuticals Private Limited is U33111WB2014PTC204431.

Where is Bellissa Pharmaceuticals Private Limited headquartered?

Bellissa Pharmaceuticals Private Limited is headquartered at 17/43, N.S.C Bose Road 2/30, Ashoke Nagar, Kolkata, West Bengal, 700040.

When was Bellissa Pharmaceuticals Private Limited incorporated?

Bellissa Pharmaceuticals Private Limited was incorporated on 27 November 2014.

Who are the current directors of Bellissa Pharmaceuticals Private Limited?

The current directors of Bellissa Pharmaceuticals Private Limited are

What is the primary industry of Bellissa Pharmaceuticals Private Limited?

The primary industry of Bellissa Pharmaceuticals Private Limited is Trade.

Is Bellissa Pharmaceuticals Private Limited a listed company?

Bellissa Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Bellissa Pharmaceuticals Private Limited?

The authorized capital of Bellissa Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹0.75 M.

What is the compliance status of Bellissa Pharmaceuticals Private Limited?

The compliance status of Bellissa Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available